The Intersection of SARS-CoV-2 and Diabetes

Area of Science:

• Endocrinology
• Virology
• Immunology

Background:

• Comorbidities significantly impact viral infection severity.
• Diabetes Mellitus (DM), characterized by hyperglycemia, elevates risks during viral infections like SARS-CoV-2.
• Hyperglycemia drives inflammation, metabolic dysfunction, and immune dysregulation.

Purpose of the Study:

• To elucidate mechanisms linking DM to severe COVID-19.
• To explore how COVID-19 may induce new-onset diabetes.
• To emphasize SARS-CoV-2's impact on metabolic health.

Main Methods:

• Literature review focusing on the interplay between diabetes and viral infections.
• Analysis of mechanisms involving ACE2 expression and viral replication.
• Exploration of COVID-19's effects on glucose metabolism.

Main Results:

• DM exacerbates COVID-19 severity through hyperglycemia-induced inflammation and immune dysregulation.
• Diabetes may enhance viral replication by increasing ACE2 expression and providing a conducive cellular environment.
• COVID-19 infection is linked to the development of new-onset diabetes.

Conclusions:

• The bidirectional relationship between diabetes and COVID-19 has significant implications for metabolic health.
• Understanding these interactions is crucial for managing patients with both conditions.
• The SARS-CoV-2 pandemic poses challenges to metabolic health management.